BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 19928013)

  • 1. [4th Congress of ECCO (5-7 February 2009, Hamburg (Germany). (The European Crohn's and Colitis Organization)--Inflammatory bowel diseases 2009)].
    Baryshnikov EN; Kniazev OV
    Eksp Klin Gastroenterol; 2009; (3):158-60. PubMed ID: 19928013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. European Crohn's and Colitis Organisation Topical Review on IBD in the Elderly.
    Sturm A; Maaser C; Mendall M; Karagiannis D; Karatzas P; Ipenburg N; Sebastian S; Rizzello F; Limdi J; Katsanos K; Schmidt C; Jeuring S; Colombo F; Gionchetti P
    J Crohns Colitis; 2017 Mar; 11(3):263-273. PubMed ID: 27797918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus.
    Bourreille A; Ignjatovic A; Aabakken L; Loftus EV; Eliakim R; Pennazio M; Bouhnik Y; Seidman E; Keuchel M; Albert JG; Ardizzone S; Bar-Meir S; Bisschops R; Despott EJ; Fortun PF; Heuschkel R; Kammermeier J; Leighton JA; Mantzaris GJ; Moussata D; Lo S; Paulsen V; Panés J; Radford-Smith G; Reinisch W; Rondonotti E; Sanders DS; Swoger JM; Yamamoto H; Travis S; Colombel JF; Van Gossum A;
    Endoscopy; 2009 Jul; 41(7):618-37. PubMed ID: 19588292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: results of the 2011 ECCO-EpiCom inception cohort.
    Vegh Z; Burisch J; Pedersen N; Kaimakliotis I; Duricova D; Bortlik M; Avnstrøm S; Vinding KK; Olsen J; Nielsen KR; Katsanos KH; Tsianos EV; Lakatos L; Schwartz D; Odes S; Lupinacci G; De Padova A; Jonaitis L; Kupcinskas L; Turcan S; Tighineanu O; Mihu I; Barros LF; Magro F; Lazar D; Goldis A; Fernandez A; Hernandez V; Niewiadomski O; Bell S; Langholz E; Munkholm P; Lakatos PL;
    J Crohns Colitis; 2014 Nov; 8(11):1506-15. PubMed ID: 24998983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inflammatory bowel disease: an overview].
    Herrlinger K
    Med Monatsschr Pharm; 2013 Nov; 36(11):402-8; quiz 409. PubMed ID: 24640117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Definitions of Histological Abnormalities in Inflammatory Bowel Disease: an ECCO Position Paper.
    Feakins R; Borralho Nunes P; Driessen A; Gordon IO; Zidar N; Baldin P; Christensen B; Danese S; Herlihy N; Iacucci M; Loughrey MB; Magro F; Mookhoek A; Svrcek M; Rosini F
    J Crohns Colitis; 2024 Feb; 18(2):175-191. PubMed ID: 37607017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologics in Pediatric Inflammatory Bowel Disease.
    Kleinhenz J; Wagner E
    Pediatr Ann; 2022 Feb; 51(2):e77-e81. PubMed ID: 35156888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a prodromal period in Crohn's disease but not ulcerative colitis.
    Pimentel M; Chang M; Chow EJ; Tabibzadeh S; Kirit-Kiriak V; Targan SR; Lin HC
    Am J Gastroenterol; 2000 Dec; 95(12):3458-62. PubMed ID: 11151877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric Inflammatory Bowel Disease Clinical Innovations Meeting of the Crohn's & Colitis Foundation: Charting the Future of Pediatric IBD.
    Picoraro JA; Lee D; Heller CA; Weaver A; Hyams JS; Conklin LS; Otley A; Ziring D; Kugathasan S; Rosh JR; Mulberg A; Denson LA; Kappelman MD; Grossman AB; Bousvaros A; Park KT
    Inflamm Bowel Dis; 2019 Jan; 25(1):27-32. PubMed ID: 29931102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review article: novel oral-targeted therapies in inflammatory bowel disease.
    White JR; Phillips F; Monaghan T; Fateen W; Samuel S; Ghosh S; Moran GW
    Aliment Pharmacol Ther; 2018 Jun; 47(12):1610-1622. PubMed ID: 29672874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International variation in medication prescription rates among elderly patients with inflammatory bowel disease.
    Benchimol EI; Cook SF; Erichsen R; Long MD; Bernstein CN; Wong J; Carroll CF; Frøslev T; Sampson T; Kappelman MD
    J Crohns Colitis; 2013 Dec; 7(11):878-89. PubMed ID: 23018106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a Core Outcome Set for Real-world Data in Inflammatory Bowel Disease: A European Crohn's and Colitis Organisation [ECCO] Position Paper.
    Hanzel J; Bossuyt P; Pittet V; Samaan M; Tripathi M; Czuber-Dochan W; Burisch J; Leone S; Saldaña R; Baert F; Kopylov U; Jäghult S; Adamina M; Arebi N; Gecse K
    J Crohns Colitis; 2023 Apr; 17(3):311-317. PubMed ID: 36190188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Report on participation in the 7th International Congress on studying Crohn's Disease and Ulcerative Colitis (ECCO) (15-18 February, 2012), Barcelona (Spain)].
    Kniazev OV; Sagynbaeva VE
    Eksp Klin Gastroenterol; 2012; (3):124-5. PubMed ID: 22830237
    [No Abstract]   [Full Text] [Related]  

  • 14. East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort.
    Burisch J; Pedersen N; Čuković-Čavka S; Brinar M; Kaimakliotis I; Duricova D; Shonová O; Vind I; Avnstrøm S; Thorsgaard N; Andersen V; Krabbe S; Dahlerup JF; Salupere R; Nielsen KR; Olsen J; Manninen P; Collin P; Tsianos EV; Katsanos KH; Ladefoged K; Lakatos L; Björnsson E; Ragnarsson G; Bailey Y; Odes S; Schwartz D; Martinato M; Lupinacci G; Milla M; De Padova A; D'Incà R; Beltrami M; Kupcinskas L; Kiudelis G; Turcan S; Tighineanu O; Mihu I; Magro F; Barros LF; Goldis A; Lazar D; Belousova E; Nikulina I; Hernandez V; Martinez-Ares D; Almer S; Zhulina Y; Halfvarson J; Arebi N; Sebastian S; Lakatos PL; Langholz E; Munkholm P;
    Gut; 2014 Apr; 63(4):588-97. PubMed ID: 23604131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspects of human disease.
    Scully C; Chaudhry SI
    Dent Update; 2007 Jun; 34(5):317. PubMed ID: 17624150
    [No Abstract]   [Full Text] [Related]  

  • 16. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrasting Pattern of Chronic Inflammatory Bowel Disease in Primary and Autoimmune Sclerosing Cholangitis.
    Bjarnason I; Hayee B; Pavlidis P; Kvasnovsky C; Scalori A; Sisson G; Charlesworth A; Shaikh H; Bjornsson E; Heneghan MA
    EBioMedicine; 2015 Oct; 2(10):1523-7. PubMed ID: 26629548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory bowel diseases in anti-neutrophil cytoplasmic antibody-associated vasculitides: 11 retrospective cases from the French Vasculitis Study Group.
    Humbert S; Guilpain P; Puéchal X; Terrier B; Rivière S; Mahr A; Pagnoux C; Bagnères D; Cordier JF; Le Quellec A; Altwegg R; Guillevin L;
    Rheumatology (Oxford); 2015 Nov; 54(11):1970-5. PubMed ID: 26106214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viewpoint: knowledge and viewpoints on biosimilar monoclonal antibodies among members of the European Crohn's and Colitis Organization.
    Danese S; Fiorino G; Michetti P
    J Crohns Colitis; 2014 Nov; 8(11):1548-50. PubMed ID: 25008477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.